Teva enjoyed $3.3B in Israeli tax breaks; India's Cipla wraps Cipla Medpro buyout; Merck KGaA eyes collaborations in Korea;

 @FiercePharma: China's corruption watchdogs eye 4 more drugmakers as GSK manager confesses to bribery on TV. More | Follow @FiercePharma

@CarlyHFierce: NICE says no to Pfizer's Bosulif. Been pretty skeptical about new cancer drugs. Release | Follow @CarlyHFierce

> Teva Pharmaceutical ($TEVA) reaped nearly 12 billion shekels ($3.3 billion) in tax breaks between 2006 and 2011, the Israeli government's Tax Authority says. Report

> India's Cipla wrapped up its buyout of South African affiliate Cipla Medpro for 4.51 billion rand, or about $457 million. Report

> Merck KGaA's new CEO in Korea says he's looking for "seamless collaboration" with local biotech companies. Report

> Pharma machinery makers in China want the government to impose a dumping duty on imports, saying a lack of restrictions is hurting domestic companies. Report

> The FDA approved the first brain wave test to identify children with attention deficit hyperactivity disorder. Report

> The decline in cholesterol levels in the U.S. has leveled off, triggering worries about gains in cardiovascular health. Report

Medical Device News

 @FierceMedDev: Boston Scientific, Sorin team up on heart valve. Article | Follow @FierceMedDev

 @MarkHFierce: The FDA approved the first Dx test designed to help diagnose ADHD in children and teens. EEG tech is a core element. Press release | Follow @MarkHFierce

 @DamianFierce: No Synthes, no growth for JNJ's medical devices and diagnostics business. Report | Follow @DamianFierce

> Myriad ups patient assistance as it sues cheaper rivals. Story

> NEA invests $4.3M in Cartiva's joint replacement work. Item

Biotech News

 @FierceBiotech: ICYMI: Merck's positive Alzheimer's study spotlights BACE race. Article | Follow @FierceBiotech

 @JohnCFierce: In pharma, incremental innovation lives on. Story | Follow @JohnCFierce

 @RyanMFierce: A $30.6M financing for Ayasdi, BigData analytics and discovery for life sciences, energy and other industries. Release | Follow @RyanMFierce

> $350M batch of biotech IPOs to test investors' appetite for risk. Story

> Rumors of big Roche bid for Alexion cool as analysts weigh in. News

Biotech Research News

 @EmilyMFierce: Obesity gene found to regulate hunger hormone. More | Follow @EmilyMFierce

> Researchers unveil largest database of cancer-related genetic variations. News

> Senate committee approves funding increase for NIH in FY 2014. Article

> Sorrento Therapeutics, Israeli university team up to fight hep C. Item

Pharma Manufacturing News

 @EricPFierce: BTG said its Biocompatibles unit had received an FDA warning letter for its plant in Oxford, CT. Article | Follow @EricPFierce

> FDA lays out when plant inspection delays will lead to penalties. Report

> Roche to put $105M into training center. News

> Sanofi starts production on complex dengue vaccine. Article

And Finally... Scientists have discovered how the "obesity gene" increases hunger. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.